MedPage Today on MSN
New CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D
The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...
Woman's World on MSN
New Medicare BALANCE program could slash GLP-1 costs to $50 a copay — here's who qualifies and when it starts
Major Medicare and Medicaid changes are on their way now that the Centers for Medicare & Medicaid Services (CMS) has ...
CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes weeks following the White House’s ...
Access to GLP-1 weight loss drugs could improve the long-term health and well-being for millions of Americans.
U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback